Kinder Morgan Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Kinder Morgan Inc trades at $32.47 (market cap $72.48B), while State Street SPDR S&P Biotech ETF trades at $154.46. The key difference: Kinder Morgan Inc pays a 3.61% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals.
| KMI | XBI | |
|---|---|---|
Market Cap | $72.48B | — |
Sector | Energy | Broad Market / Factor |
52-Week High | $34.31 | $164.28 |
52-Week Low | $25.84 | $85.16 |
Enterprise Value | $104.36B | — |
Dividend Yield | 3.61% | — |
Trailing returns across standard periods
Latest headlines on both assets
Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 83,000 miles in pipelines and over 140 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
Read more on KMI →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →